Key result
Long-term ANP infusion significantly improved hemodynamics in severe acute heart failure, decreasing mean pulmonary capillary wedge pressure from 23 to 13 mm Hg at 48 hours.
Why the study?
Does long-term atrial natriuretic peptide (ANP) infusion improve hemodynamic parameters and diuresis in patients with severe acute heart failure resistant to various therapies?
RCT (n=36)
Does long-term atrial natriuretic peptide (ANP) infusion improve hemodynamic parameters and diuresis in patients with severe acute heart failure resistant to various therapies?
Long-term ANP infusion significantly improves hemodynamics and diuresis without tolerance in patients with severe, therapy-resistant acute heart failure.
Answers are grounded in this paper and cite their sources.
Supports ANP consideration in refractory acute HF; hypothesis-generating and requires RCTs before practice change.
A short-term treatment of atrial natriuretic peptide (ANP), a circulating hormone of cardiac origin, is reported to improve cardiac performance in patients with chronic heart failure. However, clinical usefulness of long-term administration of ANP in patients with congestive heart failure has not been reported. We studied 36 patients with severe acute heart failure who resisted various therapy. Hemodynamic parameters were measured before and 48 h after initiating ANP infusion (n = 18) or normal saline (n = 18). Mean pulmonary capillary wedge pressure (23-->13 mm Hg), mean right atrial pressure (10-->5 mm Hg), systemic vascular resistance (2,169-->1,307 dyn x s x cm(-5)) and pulmonary vascular resistance (318-->136 dyn x s x cm(-5)) decreased significantly, whereas cardiac index (1.9-->2.6 L/min/m2) and urine volume (1,692-->2,560 ml/day) increased during long-term ANP infusion (before-->48 h). Moreover, in eight patients with long-term ANP infusion, these hemodynamic effects were maintained at 7 days after initiating ANP infusion. Vasodilating, pulmonary vasorelaxant, and diuretic activities of ANP are maintained without tolerance, and thus long-term ANP infusion is clinically useful in patients with severe acute heart failure.
No takes yet. Share an insight, caveat, or question.
Kitashiro et al. (1999) conducted an RCT in severe acute heart failure (n=36). Atrial natriuretic peptide (ANP) infusion vs. Normal saline was evaluated on Hemodynamic parameters at 48 hours. Long-term ANP infusion significantly improved hemodynamics in severe acute heart failure, decreasing mean pulmonary capillary wedge pressure from 23 to 13 mm Hg at 48 hours.
Synapse has enriched 10 related papers. Consider them for comparative context: